{"gao_id": "GAO-24-106383", "published": "2024-02-22T12:00:00Z", "released": "2024-03-25T08:00:00Z", "summary": "The FDA oversees clinical trials and other research involving human subjects, mostly for drugs trying to get FDA approval. This includes conducting inspections in hospitals and other healthcare settings in the U.S. and abroad. Recruiting and retaining investigators for these inspections has been a challenge\u2014partly due to low compensation and heavy travel. This has resulted in fewer inspections and a less experienced workforce. FDA has...", "title": "Clinical Research: FDA Should Evaluate Its Efforts to Recruit and Retain Its Inspection Workforce", "topics": ["Human subjects research", "Compliance oversight", "Clinical trials", "Drug safety", "Medical research", "Research organizations", "Workforce shortages", "Health Care", "Labor force", "Drugs", "Medical products", "Prescription drugs", "Generic drugs"], "type": "reports-testimonies", "url": "https://www.gao.gov/products/gao-24-106383", "versions": [{"title": "Highlights Page (1 page)", "url": "https://www.gao.gov/assets/d24106383high.pdf"}, {"title": "Full Report (53 pages)", "url": "https://www.gao.gov/assets/d24106383.pdf"}, {"title": "Accessible PDF (67 pages)", "url": "https://www.gao.gov/assets/870/866454.pdf"}]}